Atrás
Rango del Día
$100.00
$1,001.00
Rango de 52 Semanas
$96.50
$1,001.00
Volumen
100
Promedio 50D / 200D
$103.96
/
$108.24
Cierre Anterior
$100.00
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 26.0 | 0.3 |
| P/B | 3.9 | 3.0 |
| ROE % | 16.0 | 3.7 |
| Net Margin % | 12.7 | 3.8 |
| Rev Growth 5Y % | 4.8 | 10.0 |
| D/E | 0.5 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$6.93
$6.38 – $7.66
|
1.89B | 1 |
| FY2029 |
$5.70
$5.25 – $6.29
|
1.74B | 1 |
| FY2028 |
$5.31
$4.89 – $5.86
|
1.65B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-20 | $2.73 | $2.98 | +9.2% |
| 2025-06-30 | $1.94 | $1.89 | -2.6% |
| 2025-02-18 | $2.26 | $22.50 | +895.6% |
| 2024-08-22 | $1.71 | $18.50 | +981.9% |
| 2024-04-18 | $2.20 | $7.72 | +250.9% |
| 2023-06-30 | $1.52 | $14.48 | +852.6% |
| 2022-12-31 | $1.81 | $23.54 | +1200.6% |
| 2022-06-30 | $1.00 | $15.15 | +1419.6% |
Dividend History
Yield
0.00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Revenue grew 4.77% annually over 5 years — modest growth
ROE of 16.00% — decent returns on equity
Generating 9.98M in free cash flow
Crecimiento
Revenue Growth (5Y)
4.77%
Revenue (1Y)2.62%
Earnings (1Y)5.42%
FCF Growth (3Y)-62.65%
Calidad
Return on Equity
16.00%
ROIC9.26%
Net Margin12.70%
Op. Margin15.84%
Seguridad
Debt / Equity
0.51
Current Ratio2.00
Interest Coverage29.47
Valoración
P/E Ratio
25.96
Forward P/EN/A
P/B Ratio3.88
EV/EBITDA23.06
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.62% | Revenue Growth (3Y) | 2.22% |
| Earnings Growth (1Y) | 5.42% | Earnings Growth (3Y) | 22.32% |
| Revenue Growth (5Y) | 4.77% | Earnings Growth (5Y) | 15.26% |
| Profitability | |||
| Revenue (TTM) | 1.33B | Net Income (TTM) | 168.74M |
| ROE | 16.00% | ROA | 7.83% |
| Gross Margin | 26.54% | Operating Margin | 15.84% |
| Net Margin | 12.70% | Free Cash Flow (TTM) | 9.98M |
| ROIC | 9.26% | FCF Growth (3Y) | -62.65% |
| Safety | |||
| Debt / Equity | 0.51 | Current Ratio | 2.00 |
| Interest Coverage | 29.47 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 25.96 | Forward P/E | N/A |
| P/B Ratio | 3.88 | P/S Ratio | 3.30 |
| PEG Ratio | 5.70 | Forward PEG | N/A |
| EV/EBITDA | 23.06 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 0.23% | ||
| Market Cap | 4.38B | Enterprise Value | 4.85B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.33B | 1.29B | 1.27B | 1.23B | 1.10B |
| Net Income | 168.74M | 160.06M | 112.77M | 156.49M | 95.60M |
| EPS (Diluted) | 3.85 | 3.69 | 2.62 | 3.63 | 2.20 |
| Gross Profit | 352.56M | 329.06M | 320.41M | 318.89M | 239.57M |
| Operating Income | 210.43M | 199.26M | 172.07M | 230.78M | 131.95M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.15B | 1.93B | 1.86B | 1.79B | 1.67B |
| Total Liabilities | 1.03B | 953.81M | 1.02B | 1.00B | 980.94M |
| Shareholders' Equity | 1.13B | 980.19M | 838.24M | 790.93M | 688.22M |
| Total Debt | 575.48M | 490.10M | 525.00M | 590.00M | 560.00M |
| Cash & Equivalents | 103.13M | 38.76M | 56.36M | 91.48M | 72.62M |
| Current Assets | 1.05B | 939.38M | 983.16M | 944.89M | 826.17M |
| Current Liabilities | 524.98M | 306.60M | 397.80M | 317.59M | 270.79M |